1600016N20Rik Activators consist of a variety of chemical compounds that enhance the functional activity of 1600016N20Rik through diverse and specific signaling pathways. Forskolin, by increasing adenylate cyclase activity, and consequently intracellular cAMP, activates PKA, which could phosphorylate and enhance the activity of 1600016N20Rik. Similarly, PMA and DiC8 serve as activators of PKC, a kinase that may phosphorylate 1600016N20Rik, thus amplifying its activity. The role of calcium signaling is underscored by Ionomycin, which elevates intracellular calcium and potentially activates CaMKs that could phosphorylate 1600016N20Rik, while sphingosine-1-phosphate signals through its receptors to initiate phosphorylation cascades that enhance 1600016N20Rik activity. The insulin pathway is another conduit, with insulin binding to its receptor, initiating a cascade through PI3K/Akt that might culminate in the activation of 1600016N20Rik.
EGCG, by inhibiting competitive kinases, and retinoic acid, through modulation of gene expression, provide a biochemical environment conducive to the selective activation of 1600016N20Rik. The administration of 8-Br-cAMP, a cAMP analog, ensures the sustained activity of PKA, which is crucial for the phosphorylation and subsequent activation of 1600016N20Rik. Anisomycin, a stress-activated protein kinase activator, introduces another layer of regulation that could enhance 1600016N20Rik via the SAPK/JNK pathway. Additionally, the phosphatase inhibitor Calyculin A preserves the phosphorylated state of 1600016N20Rik, preventing its deactivation. Bisindolylmaleimide I, through PKC inhibition, selectively shifts phosphorylation events towards pathways that involve 1600016N20Rik, subtly enhancing its activity by reducing competing phosphorylations. Collectively, these compounds facilitate the enhancement of 1600016N20Rik's function by engaging with specific cellular signaling pathways, ensuring the protein's activation without direct binding or upregulating its expression levels.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA acts as a direct activator of protein kinase C (PKC) which, upon activation, can phosphorylate multiple substrates including those that could enhance the activity of 1600016N20Rik. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases (CaMKs) potentially leading to the activation of 1600016N20Rik by phosphorylation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can lead to downstream phosphorylation events enhancing the activity of 1600016N20Rik. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Insulin activates the insulin receptor, which triggers the PI3K/Akt signaling pathway, potentially resulting in the phosphorylation and enhancement of 1600016N20Rik activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG inhibits a broad range of kinases, potentially reducing competitive phosphorylation and thus allowing for the preferential activation of 1600016N20Rik by specific kinases. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $106.00 $166.00 $289.00 $550.00 $819.00 | 2 | |
As a cAMP analog, 8-Br-cAMP elevates PKA activity which could phosphorylate and enhance the activity of 1600016N20Rik. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid modulates gene expression through its receptors which could lead to upregulation of kinases or phosphatases that specifically enhance the phosphorylation state of 1600016N20Rik. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $46.00 $249.00 | 2 | |
DiC8 is a synthetic analog of diacylglycerol (DAG) and can activate PKC, potentially leading to phosphorylation and activation of 1600016N20Rik. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that might lead to the selective activation of pathways involving 1600016N20Rik by reducing PKC-mediated phosphorylation of competitive substrates. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $160.00 $750.00 | 59 | |
Calyculin A is a phosphatase inhibitor that could prevent dephosphorylation of 1600016N20Rik, thus maintaining it in an active phosphorylated state. | ||||||